Impact of Time-To-Treatment on Outcomes in Autoimmune Membranous Nephropathy
In patients with aMN requiring immunosuppression, delayed treatment leads to worse kidney outcomes. A simple categorization using baseline eGFR and uPCR can help predict spontaneous remission and potential kidney function decline.
Authors
- Mrityunjay Hiremath
- Sebastian Bate (ORCID: https://orcid.org/0000-0002-2218-503X)
- Patrick Hamilton (ORCID: https://orcid.org/0000-0001-6703-3745)
- Durga Kanigicherla (ORCID: https://orcid.org/0000-0003-3011-7878)
- Anirudh Rao (ORCID: https://orcid.org/0000-0002-3202-2832)
- Omar Ragy (ORCID: https://orcid.org/0000-0003-0958-2783)
- Arif Khwaja (ORCID: https://orcid.org/0000-0002-4690-3649)
- Samar Bukhari
Institutions
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Manchester Academic Health Science Centre (GB)
- Wellcome Centre for Cell-Matrix Research (GB)
- University of Manchester (GB)
- Manchester University NHS Foundation Trust (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1016/j.ekir.2025.04.005
- Citations
- 4
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 5.72